APO-Mometasone nasal spray recalled due to infection risk

WNews
WNews 1 Min Read

Drug company Apotex is recalling two lots of a prescription nasal spray because of possible bacterial contamination.

APO-Mometasone nasal spray is prescribed for allergy symptoms in children, for sinusitis in patients aged 12 and older and for nasal polyps in adults.

Health Canada says the recalled lots may be contaminated with Burkholderia cepacia complex bacteria, which can pose serious health risks to people with chronic lung diseases or weakened immune systems, those who are pregnant, as well as seniors and children.

The affected APO-Mometasone sprays are from lot numbers TX5343 and TZ2586 and have expiry dates of September and October 2025.

- Advertisement -

Health Canada says anyone

Share This Article
Leave a comment
Report a Bug/Suggest Feature

Notice a bug on the site or want to suggest a feature. Please fill out the information below and one of our IT will look at the bug/feature report. If we have any questions or want more information, we will reach out vis email.

Reading: APO-Mometasone nasal spray recalled due to infection risk

(C) 2012 – 2024  | WNews Broadcasting Corp, a W-World Company | All Rights Reserved

Connect
with Us

Report a Error with this Story

Notice a error or facts with this story, please submit the information below and someone from our newsroom will review it and change if required 

Beta

Welcome to The New W.News

It is with great pleasure that we welcome you to W.News 6, the most extensive update ever. Please bear with us as we continue to work on and fine tune the new site. WNewsNetwork.com will remain online until June 30, 2024.